Naramune-2, Intranasal, 5 dose

Canine Kennel Cough Vaccine.
Canine Parainfluenza-Bordetella Bronchiseptica Vaccine, Modified Live Virus, Avirulent Live Culture

Contents: This product contains the antigens listed above.
Preservative: Neomycin.
Indications: For vaccination of healthy susceptible dogs and puppies against Canine Upper Respiratory Infection (Canine Cough) caused by canine parainfluenza and Bordetella bronchiseptica. Field studies support the safety of Naramune-2 when administered to puppies as young as 3 weeks of age.
Dosage and Administration: Rehydration: Rehydrate to desired dose volume with accompanying sterile diluent. For five 0.5 mL doses, reconstitute with 2.5 mL of diluent. For five 1 mL doses, reconstitute with 5 mL of diluent. Shake well and use immediately.
Using aseptic technique, administer entire dose intranasally. Use enclosed applicator tip on hub of syringe in place of syringe needle. Apply new nasal applicator tip for each dog vaccinated. Do not vaccinate puppies under 3 weeks of age. Puppies vaccinated between 3 and 6 weeks of age should be revaccinated at 6 weeks of age. Annual revaccination is recommended.
Precaution(s): Store out of direct sunlight at a temperature between 35-45°F (2-7°C). Use entire contents when first opened. Burn containers and all unused contents.
Caution(s): For intranasal use in dogs only; do not vaccinate dogs parenterally. Anaphylactoid reactions may occur.
Antidote(s): Epinephrine.
Presentation: 20 x 1 dose (1 mL) vials.